ArticleHematology reports2026

Clinical Experience with Emicizumab and Rituximab as First-Line Treatment in a Case Series of Acquired Hemophilia A.

Hikari Ota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.